Development of breakpoints of carbapenems for intraabdominal infections based on pharmacokinetics and pharmacodynamics in peritoneal fluid
Authors:
- Kazuro IkawaKIKazuro Ikawa
- Norifumi MorikawaNMNorifumi Morikawa
- Kayo IkedaKIKayo Ikeda
- Hiroki OhgeHOHiroki Ohge
- Taijiro SuedaTSTaijiro Sueda
- 1 January 2008
- journal article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 14 (4) , 330-332
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Quantification of doripenem in human plasma and peritoneal fluid by high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B, 2008
- Pharmacokinetics and Pharmacodynamic Assessment of Imipenem in the Intraperitoneal Fluid of Abdominal Surgery PatientsChemotherapy, 2008
- Development of breakpoints of cephems for intraabdominal infections based on pharmacokinetics and pharmacodynamics in the peritoneal fluid of patientsJournal of Infection and Chemotherapy, 2008
- High-performance liquid chromatography with ultraviolet detection for real-time therapeutic drug monitoring of meropenem in plasmaJournal of Chromatography B, 2007
- Comparative Review of the CarbapenemsDrugs, 2007
- Clinical breakpoints in pulmonary infections and sepsis: new antimicrobial agents and supplemental information for some agents already releasedJournal of Infection and Chemotherapy, 1999
- Empiric Breakpoints of Antimicrobial Agents in Urinary Tract InfectionsJournal of Infection and Chemotherapy, 1998
- Derivation of a Calculation Formula for Breakpoints of Antimicrobial Agents in Urinary Tract InfectionsJournal of Infection and Chemotherapy, 1998
- Clinical Breakpoints for Antimicrobial Agents in Pulmonary Infections and Sepsis: Report of The Committee for Japanese Standards for Antimicrobial Susceptibility Testing for BacteriaJournal of Infection and Chemotherapy, 1995